Innodata’s Blowout Q2 Hides a Leadership Vacuum and a Growth Cliff

In Short

Innodata’s Q2 beat hides a leadership vacuum and a 2% sequential growth stall. EPS crushed estimates, but the stock fell 3.4% after hours—smart money is exiting. Can the new CEO sustain 58% growth without naming its mega-customer? Read the full breakdown.

The Lede and the Real Story

Innodata reported a headline-grabbing Q2 2026: revenue of $92.14 million, up 58% year-over-year, with adjusted EPS of $0.41 crushing consensus by 92%. Adjusted gross margin hit 49%, and adjusted EBITDA reached new highs. The stock, however, fell 3.39% in after-hours trading—a classic ‘sell the news’ reaction that hints investors are looking past the optics. The real story is not the growth—it’s the leadership transition announced quietly in the press release, the decelerating sequential growth (from 54% YoY in Q1 to 58% in Q2, but only $2 million in absolute revenue growth quarter-over-quarter), and the dependence on a single mega-customer that management refuses to name. The market is asking: Can this growth continue without the founder-CEO at the helm, and is the revenue quality as strong as the headline suggests?

Inside the Full Analysis

  • 🔒The Negative Space — What They Didn’t Say
  • 🔒Script vs. Reality
  • 🔒Evasion Tactics & The Hot Seat
  • 🔒Excuses vs. Execution
  • 🔒The CAN SLIM Check
  • 🔒Conclusion

Discover more from CANSLIM Research

Subscribe to get the latest posts sent to your email.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.

Discover more from CANSLIM Research

Subscribe now to keep reading and get access to the full archive.

Continue reading